This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Schott Ag. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Christian Lautenschläger
Introduction
Christian Lautenschläger is a notable inventor based in Cambridge, GB. He has made significant strides in the field of medical materials, particularly with his innovative patent that addresses the challenges of biofilm formation in medical applications. His work is crucial for enhancing the compatibility of materials used in human and animal bodies.
Latest Patents
Lautenschläger holds a patent for a medical glass element that is designed to be less populated by biofilms than existing materials. This invention is well tolerated by the body and includes a glass and/or glass ceramic and/or ceramic material that inhibits biofilm formation. The material is intended to be introduced into or attached to a human or animal body, promoting cell growth while preventing harmful biofilm accumulation. The composition of the glass and/or glass ceramic material comprises at least 60 to 75 wt % SiO and 1 to 7 wt % ZnO.
Career Highlights
Christian Lautenschläger is associated with Schott AG, a company known for its expertise in glass and glass-ceramic materials. His work at Schott AG has allowed him to focus on developing innovative solutions that improve medical applications and patient outcomes.
Collaborations
Lautenschläger collaborates with talented individuals such as Sabine Pichler-Wilhelm and Oliwia Makarewicz. These collaborations enhance the research and development efforts within his field, contributing to the advancement of medical technologies.
Conclusion
Christian Lautenschläger's contributions to the field of medical materials through his innovative patent demonstrate his commitment to improving healthcare solutions. His work not only addresses critical challenges in biofilm formation but also paves the way for future advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
